QTTB (Q32 Bio Inc.) Stock Financials & Earnings | Market Cap Arena

QTTB (Q32 Bio Inc.) Stock Financials & Earnings | Market Cap Arena

QTTBQ32 Bio Inc.

Mkt Cap$73M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)$30M

EPS (TTM)$2.30

Free Cash Flow (TTM)-$27M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)2.4x

YoY Rev Growth—

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$3M	$3M	-$7M
Q2 23	$3M	$3M	-$7M
Q3 23	$2M	$2M	-$8M
Q4 23	-$15M	-$15M	-$26M
Q1 24	$0	-$123K	-$15M
Q2 24	$0	-$121K	-$18M
Q3 24	$0	$0	-$19M
Q4 24	$0	$0	-$15M
Q1 25	$0	$0	-$12M
Q2 25	$0	-$91K	-$9M
Q3 25	$0	$0	-$8M
Q4 25	$0	$0	$46M

Valuation

Quarter	P/S	P/E
Q1 23	13.6x	—
Q2 23	9.4x	—
Q3 23	8.3x	—
Q4 23	—	—
Q1 24	—	—
Q2 24	—	—
Q3 24	—	—
Q4 24	—	—
Q1 25	—	—
Q2 25	—	—
Q3 25	—	—
Q4 25	—	2.4x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$12M	-$13M
Q2 23	$2M	$2M
Q3 23	$16M	$16M
Q4 23	-$11M	-$11M
Q1 24	-$15M	-$15M
Q2 24	-$22M	-$22M
Q3 24	-$20M	-$20M
Q4 24	-$11M	-$11M
Q1 25	-$12M	-$12M
Q2 25	-$11M	-$11M
Q3 25	-$4M	-$4M
Q4 25	$0	$0

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$5K
Q2 23	$224K
Q3 23	$1K
Q4 23	$0
Q1 24	$0
Q2 24	$15K
Q3 24	$58K
Q4 24	$2K
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+267.5%	-73.1%
Q2 23	+299.6%	-64.0%
Q3 23	+131.8%	-71.3%
Q4 23	-1928.2%	-68.4%
Q1 24	-100.0%	+43.8%
Q2 24	-100.0%	+71.0%
Q3 24	-100.0%	+94.8%
Q4 24	+100.0%	+30.3%
Q1 25	—	-17.6%
Q2 25	—	-48.8%
Q3 25	—	-59.7%
Q4 25	—	-415.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$296K	10.0%
Q2 23	$0	0.0%
Q3 23	$301K	16.2%
Q4 23	$0	—
Q1 24	$417K	—
Q2 24	$1M	—
Q3 24	$1M	—
Q4 24	$1M	—
Q1 25	$1M	—
Q2 25	$1M	—
Q3 25	$1M	—
Q4 25	$0	—

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 23	$8M	—	$2M
Q2 23	$8M	—	$2M
Q3 23	$7M	—	$2M
Q4 23	$8M	$3M	—
Q1 24	$10M	—	$5M
Q2 24	$13M	$5M	—
Q3 24	$14M	$4M	—
Q4 24	$11M	$4M	—
Q1 25	$7M	$5M	—
Q2 25	$5M	$4M	—
Q3 25	$4M	—	$4M
Q4 25	$3M	$5M	—

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$34M	$141M	$175M
Q1 23	$39M	$111M	$150M
Q2 23	$77M	$50M	$127M
Q3 23	$36M	$0	$36M
Q4 23	$26M	$0	$26M
Q1 24	$116M	$20M	$135M
Q2 24	$98M	$10M	$108M
Q3 24	$89M	$0	$89M
Q4 24	$78M	$0	$78M
Q1 25	$65M	$0	$65M
Q2 25	$55M	$0	$55M
Q3 25	$49M	$0	$49M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	3M	+0.4%
Q2 23	3M	+0.1%
Q3 23	3M	+0.1%
Q4 23	3M	+0.3%
Q1 24	12M	+270.5%
Q2 24	12M	+0.2%
Q3 24	12M	+0.9%
Q4 24	12M	+1.0%
Q1 25	12M	+0.0%
Q2 25	12M	+0.0%
Q3 25	12M	+0.4%
Q4 25	13M	+2.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 16	—	—
FY 17	—	—
FY 18	$43K	124
FY 19	$9K	187
FY 20	$13K	205
FY 21	$152K	224
FY 22	$72K	92
FY 23	-$950K	7
FY 24	$0	42
FY 25	$0	200K